Articles published by 4D Molecular Therapeutics, Inc.![]() ![]() ![]() ![]() Via GlobeNewswire
Tickers
FDMT
![]() ![]() Via GlobeNewswire
Tickers
FDMT
![]() ![]() ![]() Via GlobeNewswire
Tickers
FDMT
![]() ![]() Via GlobeNewswire
Tickers
FDMT
![]() ![]() ![]()
4DMT Reports Full Year 2023 Financial Results and Operational Highlights
February 29, 2024
Via GlobeNewswire
Tickers
FDMT
![]() ![]()
4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
February 06, 2024
Via GlobeNewswire
Tickers
FDMT
![]() Via GlobeNewswire
Tickers
FDMT
![]() ![]() ![]() ![]()
4DMT Highlights Recent Clinical Pipeline Progress, Near-Term Milestones and Organizational Updates
January 04, 2024
Via GlobeNewswire
Tickers
FDMT
![]() ![]() ![]() ![]()
4DMT to Participate in Upcoming Investor Conferences
November 15, 2023
Via GlobeNewswire
Tickers
FDMT
![]() Via GlobeNewswire
Tickers
FDMT
![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|